1. Genotoxicity of atrazine based herbicide evaluated by chromosomal aberration analysis and comet assay
- Author
-
Želježić , Davor, Garaj-Vrhovac , Vera, and Garcia-Sagredo , Hose
- Subjects
atrazin ,pesticid ,limfociti ,kometni test ,kromosomske aberacije - Abstract
Atrazine was introduced at the market in 1958 as a triazine herbicide used for the control of broadleaf weeds. It is mostly applied pre-emergence to corn, sorghum, coffee, wheat, sugarcane, in conifer forests, on Christmas tree farms on golf courses and residential lawns. Workers handling pesticides in their production and application are exposed to thousand fold higher concentrations of active ingredients than general population in residential exposure. Further, they are not exposed to active ingredients only, but to entire pesticide formulations. Since they contain wide range of chemical substances together with the atrazine as active ingredient we aimed to evaluate possible genotoxicity of Gesaprim ® ; as one of its commercially available formulations. Alkaline comet assay and chromosomal aberration analysis on peripheral blood lymphocytes were used to test 3 different concentration of Gesaprim expressed in terms of the final concentration of atrazine in the whole blood cultures (0, 047 μ g/ml, 0, 47 μ g/ml, 4, 7 μ g/ml). Pesticide formulation was tested in the presence of metabolic activator. Lymphocytes were treated for 30 and 8 hours. Both tail length and tail moment increased with the duration of the treatment. They were found to be significantly elevated already after 30 minutes of treatment. After the 8 hours treatment number of chromatid and chromosome breaks has been found to be significantly elevated. It was evident that genotoxicity results for pure active ingredient and commercial formulation differ significantly for the more realistic risk assessment in occupational exposure, testing of entire pesticide formulation should be considered.
- Published
- 2005